Rapid non-uniform adaptation to conformation-specific KRAS(G12C) inhibition

KRAS GTPases are activated in one-third of cancers and KRAS(G12C) is the most common activating alteration in lung adenocarcinoma(1,2). KRAS(G12C) inhibitors(3,4) are in Phase-I clinical trials and early data show partial responses in ~50% of lung cancer patients. How cancer cells bypass inhibition,...

Full description

Saved in:

Bibliographic Details
Published in:	Nature
Main Authors:	Xue, Jenny Y., Zhao, Yulei, Aronowitz, Jordan, Mai, Trang T., Vides, Alberto, Qeriqi, Besnik, Kim, Dongsung, Li, Chuanchuan, de Stanchina, Elisa, Mazutis, Linas, Risso, Davide, Lito, Piro
Format:	Artigo
Language:	Inglês
Published:	2020
Subjects:	Article
Online Access:	https://ncbi.nlm.nih.gov/pmc/articles/PMC7308074/ https://ncbi.nlm.nih.gov/pubmed/31915379 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41586-019-1884-x
Tags:	Add Tag No Tags, Be the first to tag this record!

Rapid non-uniform adaptation to conformation-specific KRAS(G12C) inhibition

Similar Items